Breaking News

Researchers scramble for answers on 'Paxlovid rebound'; FDA's in the dark on dietary supplement ingredients

  

 

Daily Recap

As reports of 'Paxlovid rebound' increase, Covid researchers scramble for answers

By Jason Mast

Bloomberg photo by Kobi Wolf

These cases raise important questions about how doctors should use Paxlovid, the most effective Covid-19 treatment to date.

Read More

STAT+: The FDA says it's in the dark about thousands of dietary supplement ingredients

By Nicholas Florko

Adobe

Despite a law requiring them to do so, supplement makers haven’t notified the FDA about roughly 3,400 ingredients they’re selling.

Read More

Amazon accessibility researcher says inclusion of people with disabilities is 'lacking' in health tech

By Isabella Cueto

STAT

"I think of the medical system as one of the most ableist institutions we still have," said Amazon accessibility researcher Joshua Miele.

Read More

Opinion: STAT+: A market failure is preventing efficient diffusion of health care AI software

By Mark P. Sendak and Nicholson Price and Suresh Balu

Adobe

Without change, low-resource hospitals will adopt poorly functioning AI software, and markets for best-in-class software will fail to emerge.

Read More

Opinion: 'This Is Us' should be remembered for its nuanced portraits of mental health, dementia, and identity

By Sarah MacCarthy and Jalondra A. Davis

Kevin Winter/Getty Images

"This Is Us" covered mental and behavioral health issues and social drivers of health with aplomb during its six seasons on television.

Read More

Tuesday, May 24, 2022

STAT

Facebook   Twitter   YouTube   Instagram

1 Exchange Pl, Suite 201, Boston, MA 02109
©2022, All Rights Reserved.
I no longer wish to receive STAT emails
Update Email Preferences | Contact Us | View In Browser

No comments